Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Salman Rafi Punekar"'
Publikováno v:
Journal of Immunotherapy. 44:335-337
Immune checkpoint inhibitors (ICIs) are a class of medications targeting mostly the PD-1/PD-L1 and CTLA-4 immune pathways in the treatment of many cancers. Despite the encouraging success of ICIs, they are associated with immune-related adverse event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d53163cdbda4198a57cfc58a0cf2b4
https://doi.org/10.1097/cji.0000000000000380
https://doi.org/10.1097/cji.0000000000000380
Autor:
Alexander Michael Barbaro, Matthew Siskin, Cassandra Grello, Adrian V Hernandez, Jared Dublin, Sean Breslin, Salman Rafi Punekar, Vamsidhar Velcheti
Publikováno v:
Journal of Clinical Oncology. 40:e21120-e21120
e21120 Background: Immune checkpoint inhibitors (ICIs) are commonly used in the treatment of non-small cell lung cancer (NSCLC), and are given alone or in combination with cytotoxic chemotherapy. These agents are sometimes associated with immune rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ce114629c69c5c705d54f980a19080f
https://doi.org/10.1200/jco.2022.40.16_suppl.e21120
https://doi.org/10.1200/jco.2022.40.16_suppl.e21120